Literature DB >> 30610108

Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin-Related Protein 2/3 Complex Activity, Invadopodia Function, and Tumor Cell Invasion.

Steven M Markwell1, Amanda G Ammer1, Erik T Interval2, Jessica L Allen1, Brenen W Papenberg1, River A Hames1, Johnathan E Castaño2, Dorothy A Schafer3, Scott A Weed4.   

Abstract

Malregulation of the actin cytoskeleton enhances tumor cell motility and invasion. The actin-binding protein cortactin facilitates branched actin network formation through activation of the actin-related protein (Arp) 2/3 complex. Increased cortactin expression due to gene amplification is observed in head and neck squamous cell carcinoma (HNSCC) and other cancers, corresponding with elevated tumor progression and poor patient outcome. Arp2/3 complex activation is responsible for driving increased migration and extracellular matrix (ECM) degradation by governing invadopodia formation and activity. Although cortactin-mediated activation of Arp2/3 complex and invadopodia regulation has been well established, signaling pathways responsible for governing cortactin binding to Arp2/3 are unknown and potentially present a new avenue for anti-invasive therapeutic targeting. Here we identify casein kinase (CK) 2α phosphorylation of cortactin as a negative regulator of Arp2/3 binding. CK2α directly phosphorylates cortactin at a conserved threonine (T24) adjacent to the canonical Arp2/3 binding motif. Phosphorylation of cortactin T24 by CK2α impairs the ability of cortactin to bind Arp2/3 and activate actin nucleation. Decreased invadopodia activity is observed in HNSCC cells with expression of CK2α phosphorylation-null cortactin mutants, shRNA-mediated CK2α knockdown, and with the CK2α inhibitor Silmitasertib. Silmitasertib inhibits HNSCC collective invasion in tumor spheroids and orthotopic tongue tumors in mice. Collectively these data suggest that CK2α-mediated cortactin phosphorylation at T24 is critical in regulating cortactin binding to Arp2/3 complex and pro-invasive activity, identifying a potential targetable mechanism for impairing HNSCC invasion. IMPLICATIONS: This study identifies a new signaling pathway that contributes to enhancing cancer cell invasion.Visual Overview: http://mcr.aacrjournals.org/content/molcanres/17/4/987/F1.large.jpg. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30610108      PMCID: PMC6445698          DOI: 10.1158/1541-7786.MCR-18-0391

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  49 in total

1.  Three-dimensional reconstructions of Arp2/3 complex with bound nucleation promoting factors.

Authors:  Xiao-Ping Xu; Isabelle Rouiller; Brian D Slaughter; Coumaran Egile; Eldar Kim; Jay R Unruh; Xiaoxue Fan; Thomas D Pollard; Rong Li; Dorit Hanein; Niels Volkmann
Journal:  EMBO J       Date:  2011-09-20       Impact factor: 11.598

Review 2.  Cortactin in cell migration and cancer at a glance.

Authors:  Stacey M MacGrath; Anthony J Koleske
Journal:  J Cell Sci       Date:  2012-04-01       Impact factor: 5.285

3.  An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.

Authors:  Christopher C Mader; Matthew Oser; Marco A O Magalhaes; Jose Javier Bravo-Cordero; John Condeelis; Anthony J Koleske; Hava Gil-Henn
Journal:  Cancer Res       Date:  2011-01-21       Impact factor: 12.701

Review 4.  Cortactin: Cell Functions of A Multifaceted Actin-Binding Protein.

Authors:  Michael Schnoor; Theresia E Stradal; Klemens Rottner
Journal:  Trends Cell Biol       Date:  2017-11-20       Impact factor: 20.808

5.  Phosphorylation of the WASP-VCA domain increases its affinity for the Arp2/3 complex and enhances actin polymerization by WASP.

Authors:  Giles O C Cory; Rainer Cramer; Laurent Blanchoin; Anne J Ridley
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

6.  p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate.

Authors:  Ratna K Vadlamudi; Feng Li; Christopher J Barnes; Rozita Bagheri-Yarmand; Rakesh Kumar
Journal:  EMBO Rep       Date:  2004-01-23       Impact factor: 8.807

7.  Perineural invasion in squamous cell carcinoma of the head and neck.

Authors:  J J Fagan; B Collins; L Barnes; F D'Amico; E N Myers; J T Johnson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-06

8.  Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity.

Authors:  D Basu; T-T K Nguyen; K T Montone; G Zhang; L-P Wang; J A Diehl; A K Rustgi; J T Lee; G S Weinstein; M Herlyn
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

9.  WAVE2 is regulated by multiple phosphorylation events within its VCA domain.

Authors:  Shirin M Pocha; Giles O Cory
Journal:  Cell Motil Cytoskeleton       Date:  2009-01

Review 10.  Cortactin in cancer cell migration and invasion.

Authors:  Miao Yin; Wenqing Ma; Liguo An
Journal:  Oncotarget       Date:  2017-09-19
View more
  4 in total

1.  A complex of distal appendage-associated kinases linked to human disease regulates ciliary trafficking and stability.

Authors:  Abdelhalim Loukil; Chloe Barrington; Sarah C Goetz
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

Review 2.  Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise.

Authors:  Janeen H Trembley; Betsy T Kren; Muhammad Afzal; George A Scaria; Mark A Klein; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2022-09-17       Impact factor: 3.842

Review 3.  Integrins: Moonlighting Proteins in Invadosome Formation.

Authors:  Rafael Peláez; Ana Pariente; Álvaro Pérez-Sala; Ignacio M Larrayoz
Journal:  Cancers (Basel)       Date:  2019-05-02       Impact factor: 6.639

4.  Casein kinase 2 promotes the TGF-β-induced activation of α-tubulin acetyltransferase 1 in fibroblasts cultured on a soft matrix.

Authors:  Eunae You; Jangho Jeong; Jieun Lee; Seula Keum; Ye Eun Hwang; Jee-Hye Choi; Sangmyung Rhee
Journal:  BMB Rep       Date:  2022-04       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.